← Insider buys
MRNA

Moderna, Inc. · Healthcare

Director Noubar Afeyan sold $1.9M of Moderna, Inc.

Sold$1,885,700
$188.57Price
10,000Shares

What MRNA did after the filing

Filed Jan 13Copier in Jan 17
The stock from Tue, Jan 17 open, $187.90
−27.8%
S&P 500, same days
−0.9%

Measured over 30 trading days, to the Mar 1 close.

Traded Wed, Jan 11. Filed Fri, Jan 13, 7:30 PM ET, after the close. Returns use the Jan 17 open and the Mar 1 close. Not investment advice.